Augmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab.

Barr, Paul M

Augmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 05 2019 - 1151-1153 p. digital

Publication Type: Editorial; Comment

1527-7755

10.1200/JCO.19.00419 doi


Humans
Lenalidomide
Lymphoma, Mantle-Cell
Lymphoma, Non-Hodgkin
Rituximab